SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY: A Randomized Controlled Crossover Study

To evaluate the effect of spironolactone, a mineralocorticoid receptor antagonist, for nonresolving central serous chorioretinopathy. METHODS: This is a prospective, randomized, double-blinded, placebo-controlled crossover study. Sixteen eyes of 16 patients with central serous chorioretinopathy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bousquet, Elodie, Beydoun, Talal, Rothschild, Pierre-Raphaël, Bergin, Ciara, Zhao, Min, Batista, Rui, Brandely, Marie-Laure, Couraud, Benedicte, Farman, Nicolette, Gaudric, Alain, Chast, François, Behar-Cohen, Francine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Retina 2015
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697359/
https://www.ncbi.nlm.nih.gov/pubmed/26017871
http://dx.doi.org/10.1097/IAE.0000000000000614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697359/
https://www.ncbi.nlm.nih.gov/pubmed/26017871
http://dx.doi.org/10.1097/IAE.0000000000000614

Ejemplares similares